The Competition Commission is investigating Hetero SA for alleged price collusion in bids for SA’s major HIV drug tender involving the TLD combination pill. – BusinessDay (19 Nov 2025)
Ascendis Health will delist from the JSE in early December after 93% of shareholders backed the move, signalling strong support for its turnaround strategy, reported BusinessDay (19 Nov 2025).
Hetero SA, the SA arm of Indian generics manufacturer Hetero, launched an urgent High Court challenge against the Department of Health after being excluded from the new R15.5bn HIV drug tender, reported Business Day (18 Nov 2025)
Judge Benita Whitcher of the Gauteng Labour Court dismissed the application of Gauteng Health head of department Lesiba Malotana to overturn his suspension by Premier Panyaza Lesufi in October, reported The Citizen (18 Nov 2025).